| |
|
|
| |
Transmucosal Drug Delivery
Markets & Prospects for Films, Sprays,
Lozenges, Wafers & Tablets
|
Publication: May 2011
Product Code: TMC599S
|
In their search for alternative delivery methods that will
enhance compliance and improve safety, drug developers and
researchers are discovering that the permeability of mucous
membranes provides a convenient route for the systemic
delivery of new and existing therapeutic drugs. Transmucosal
delivery offers the potential for once daily dosing of oral
drugs and avoids the effects of first pass metabolism. On
the provider side, the development of alternative methods of
drug administration has improved the ability of physicians
to manage specific problems. Practitioners now recognize the
rapid onset, relative reliability, and the general lack of
patient discomfort when drugs are administered by the
transmucosal route. We expect this market to experience
healthy growth through 2015 as buccal technology is applied
to existing drugs and as transmucosal formulations become an
important route of administration for an increasing number
of new NCEs. Growth in this sector will also be driven by
the pressure to extend market protection for numerous
existing drugs with soon-to-expire patents. |
|
Highlights |
· Analyzes and evaluates
transmucosal drug delivery technology platforms and
their impact on the market
· Analyzes transmucosal
drug products and pipeline product candidates
· Provides
assessments of key therapeutic categories
· Provides market data
and forecasts to 2015
· Profiles market
participants, their product development
activities and strategies
|
|
Summary of Contents |
Executive Summary
Drug Delivery Market
Dynamics
Evolution in Drug Development
Market and Demand Drivers
Shifting Patient Demographics
The Impact of Generics
Managed
Care Initiatives
Competitive Landscape
Competing Transmucosal Delivery Technologies
Oral Sprays
Buccal Films and
Tablets
Sublingual Films and Wafers
Commercial Transmucosal Formulation Platforms
BEMA
Bioadhesive Delivery
System
Chisys
Corplex
Intravail
Lauriad
Mistocine
Mucoadhesive Technology
OraDisc
OraVescent
RapidMist
Transmucosal Film
Oral Drug Spray Technology
Factors
Absorption
Bioavailability
Adhesion
Pharmacokinetics
FDA-Approved Transmucosal
Products
Pain Management
Fentany
Abstral
ACtiq
UNbranded
Fentora
Onsolis
Buprenorphine
Edluar
Ergoloid
Mesylates
Ergomar
Isosorbide
dinitrate, Unbranded
Nitroglycerin
NitroMist
Nitrolingual
Nitrostat
Oravig
Saphris
Striant
Suboxone/Subutex
Zolpimist
Important Pipeline Transmucosal
Product Candidates
Acyclovir Lauriad
BEMA
Buprenorphine
Fentanyl Oral Spray
Fipamezole/JP-1730
Oral-lyn
Sativex
Sumatriptan
Zensana
Transmucosal Market Assessments & Forecasts
Addiction
Anti-infectives
Cardiology
Diabetes
Infectious Disease
Neurology
Oncology
Pain Management
Sexual Health
Vaccines
Market Factors
Formulations and Proprietary Platforms
Government Regulations
Patent Expiration
and Rx-to-OTC Switching
Market Participant
Profiles
|
| |
|
|
|
|
